U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
184021184021IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of EndocarditisCompletedNo Results AvailableEndocarditis, BacterialBehavioral: Modification of therapyhttps://ClinicalTrials.gov/show/NCT00144885
184022184022LAMICTAL (Lamotrigine) For The Treatment Of Absence SeizuresCompletedNo Results AvailableEpilepsy|Seizure, AbsenceDrug: lamotriginehttps://ClinicalTrials.gov/show/NCT00144872
184023184023Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic Obstructive|Chronic Obstructive Pulmonary Disease (COPD)Drug: SB681323https://ClinicalTrials.gov/show/NCT00144859
184024184024Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In ChildrenCompletedNo Results AvailableAirway Disease|Asthma|Acute WheezingDrug: albuterol sulfate inhalation aerosolhttps://ClinicalTrials.gov/show/NCT00144846
184025184025Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsTerminatedNo Results AvailableHIV-1Drug: fosamprenavir/ritonavir (700mg/100mg BID)|Drug: fosamprenavir/ritonavir (1400mg/100mg BID)|Drug: fosamprenavir/lopinavir/ritonavir (1400mg/533mg/100mg BID)https://ClinicalTrials.gov/show/NCT00144833
184026184026Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee OsteoarthritisActive, not recruitingNo Results AvailableOsteoarthritis, KneeDrug: Injection of Hyaluronan or Salinehttps://ClinicalTrials.gov/show/NCT00144820
184027184027ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell LymphomaCompletedNo Results AvailableDiffuse Large Cell LymphomaDrug: rituximab|Drug: doxorubicin|Drug: cyclophosphamide|Procedure: autologous stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00144807
184028184028Mucopolysaccharidosis I (MPS I) RegistryRecruitingNo Results AvailableMucopolysaccharidosis I (MPS I)https://ClinicalTrials.gov/show/NCT00144794
184029184029A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) DiseaseCompletedHas ResultsMucopolysaccharidosis I|Hurler's Syndrome|Hurler-Scheie Syndrome|Scheie SyndromeBiological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)|Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)|Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)|Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)https://ClinicalTrials.gov/show/NCT00144781
184030184030A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated PatientsCompletedNo Results AvailableMucopolysaccharidosis I|Hurler's Syndrome|Hurler-Scheie Syndrome|Scheie's SyndromeDrug: laronidasehttps://ClinicalTrials.gov/show/NCT00144768
184031184031R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell LymphomaCompletedNo Results AvailableDiffuse Large Cell LymphomaDrug: Darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00144755
184032184032Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated DonorCompletedNo Results AvailableAnemia, AplasticProcedure: Bone marrow transplanthttps://ClinicalTrials.gov/show/NCT00144729
184033184033Evaluation of Combined Use of ITN's and Insect Repellents Against MalariaCompletedNo Results AvailableMalariaDevice: Insect Repellent plus Insecticide Treated Nethttps://ClinicalTrials.gov/show/NCT00144716
184034184034Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNo Results AvailableHematologic Malignancies|Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma|Hodgkin's DiseaseDrug: Sirolimus|Drug: Tacrolimushttps://ClinicalTrials.gov/show/NCT00144703
184035184035E2007 Given as Adjunctive Therapy in Patients With Refractory Partial SeizuresCompletedNo Results AvailableEpilepsyDrug: E2007 (perampanel)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00144690
184036184036Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNo Results AvailableAcute Myelogenous Leukemia|Graft Versus Host Disease|Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndromes|Non-Hodgkin's Lymphoma|Hodgkin's DiseaseDrug: sirolimus|Drug: tacrolimushttps://ClinicalTrials.gov/show/NCT00144677
184037184037Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNo Results AvailableSystemic Juvenile Idiopathic ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144664
184038184038Study of MRA in Patients With Rheumatoid Arthritis (RA)CompletedNo Results AvailableRheumatoid ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144651
184039184039Procalcitonin Increase Identifies Critically Ill Patients at High Risk of MortalityCompletedNo Results AvailableSepsis - to Reduce Mortality in the Intensive Care Unithttps://ClinicalTrials.gov/show/NCT00144638
184040184040Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNo Results AvailablePolyarticular Juvenile Idiopathic ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144625
184041184041Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNo Results AvailableSystemic Juvenile Idiopathic ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144612
184042184042Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNo Results AvailableSystemic Juvenile Idiopathic ArthritisDrug: MRA(Tocilizumab)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00144599
184043184043Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPCompletedNo Results AvailableRheumatoid ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144586
184044184044Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal ImpairmentCompletedNo Results AvailableRheumatoid ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144573
184045184045Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)CompletedNo Results AvailableRheumatoid ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144560
184046184046Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JPCompletedNo Results AvailableRheumatoid ArthritisDrug: MRA(Tocilizumab)https://ClinicalTrials.gov/show/NCT00144547
184047184047Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JPCompletedNo Results AvailableRheumatoid ArthritisDrug: MRA (Tocilizumab)https://ClinicalTrials.gov/show/NCT00144534
184048184048Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)CompletedNo Results AvailableRheumatoid ArthritisDrug: MRA(Tocilizumab)|Drug: MRA placebo|Drug: MTX|Drug: MTX placebohttps://ClinicalTrials.gov/show/NCT00144521
184049184049Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)CompletedNo Results AvailableRheumatoid ArthritisDrug: MRA (Tocilizumab)|Other: current treatmenthttps://ClinicalTrials.gov/show/NCT00144508
184050184050A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyCompletedNo Results AvailableChemotherapy Induced AnemiaDrug: recombinant human erythropoietin|Drug: recombinant human erythropoietinhttps://ClinicalTrials.gov/show/NCT00144495

* Görseller ve İçerik tekif hakkına sahip olabilir